Pretest models for predicting abnormal stress single-photon emission computed tomography myocardial perfusion imaging.


Journal

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534

Informations de publication

Date de publication:
10 2021
Historique:
received: 02 08 2019
accepted: 17 10 2019
pubmed: 12 12 2019
medline: 22 3 2022
entrez: 12 12 2019
Statut: ppublish

Résumé

The frequency of abnormal stress SPECT myocardial perfusion imaging (MPS) decreased over the past decades despite an increase in the prevalence of cardiovascular risk factors. These findings strengthen the need to develop more effective strategies for appropriately referring patients with suspected coronary artery disease (CAD) to cardiac imaging. The aim of this study was to develop pretest assessment models for predicting abnormal stress MPS. We included 5,601 consecutive patients with suspected CAD, who underwent stress MPS at our academic center. Two different models were considered: a basic model including age, gender, and anginal symptoms; and a clinical model including also diabetes, hypertension, hypercholesterolemia, smoking, and family history of CAD. In patients with abnormal MPS, the basic model classified more than 75% of patients as intermediate risk, whereas only 23% were incorrectly classified as low risk. In patients with normal MPS, 45% were correctly classified as low risk and none as high risk. Basic and clinical models had a limited discriminating capacity (area under the receiver operating characteristic curve 0.644 for basic model and 0.647 for clinical model) between individuals with and without abnormal stress MPS. The decision curve analysis demonstrates a high net benefit across a range of threshold probabilities from ~ 15% to ~30% for both models. A pretest risk stratification based on traditional cardiovascular risk factors has a limited value for predicting an abnormal stress MPS in patients with suspected CAD. However, selecting a proper threshold probability enhances the appropriateness of referral to stress MPS.

Sections du résumé

BACKGROUND
The frequency of abnormal stress SPECT myocardial perfusion imaging (MPS) decreased over the past decades despite an increase in the prevalence of cardiovascular risk factors. These findings strengthen the need to develop more effective strategies for appropriately referring patients with suspected coronary artery disease (CAD) to cardiac imaging. The aim of this study was to develop pretest assessment models for predicting abnormal stress MPS.
METHODS
We included 5,601 consecutive patients with suspected CAD, who underwent stress MPS at our academic center. Two different models were considered: a basic model including age, gender, and anginal symptoms; and a clinical model including also diabetes, hypertension, hypercholesterolemia, smoking, and family history of CAD.
RESULTS
In patients with abnormal MPS, the basic model classified more than 75% of patients as intermediate risk, whereas only 23% were incorrectly classified as low risk. In patients with normal MPS, 45% were correctly classified as low risk and none as high risk. Basic and clinical models had a limited discriminating capacity (area under the receiver operating characteristic curve 0.644 for basic model and 0.647 for clinical model) between individuals with and without abnormal stress MPS. The decision curve analysis demonstrates a high net benefit across a range of threshold probabilities from ~ 15% to ~30% for both models.
CONCLUSIONS
A pretest risk stratification based on traditional cardiovascular risk factors has a limited value for predicting an abnormal stress MPS in patients with suspected CAD. However, selecting a proper threshold probability enhances the appropriateness of referral to stress MPS.

Identifiants

pubmed: 31823327
doi: 10.1007/s12350-019-01941-3
pii: 10.1007/s12350-019-01941-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1891-1902

Informations de copyright

© 2019. American Society of Nuclear Cardiology.

Références

Iskandrian AE, Hage FG. Declining frequency of ischemia detection using stress myocardial perfusion imaging. J Am Coll Cardiol 2013;61:1066-8.
doi: 10.1016/j.jacc.2012.12.009
Henzlova MJ, Duvall WL. Temporal changes in cardiac SPECT utilization and imaging findings: Where are we going and where have we been? J Nucl Cardiol 2019. https://doi.org/10.1007/s12350-019-01687-y .
doi: 10.1007/s12350-019-01687-y pubmed: 31463817
Rozanski A, Gransar H, Hayes SW, Min J, Friedman JD, Thomson LE, et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol 2013;61:1054-65.
doi: 10.1016/j.jacc.2012.11.056
Jouni H, Askew JW, Crusan DJ, Miller TD, Gibbons RJ. Temporal trends of single-photon emission computed tomography myocardial perfusion imaging in patients without prior coronary artery disease: A 22-year experience at a tertiary academic medical center. Am Heart J 2016;176:127-33.
doi: 10.1016/j.ahj.2016.03.014
Jouni H, Askew JW, Crusan DJ, Miller TD, Gibbons RJ. Temporal trends of single-photon emission computed tomography myocardial perfusion imaging in patients with coronary artery disease: A 22-year experience from a tertiary academic medical center. Circ Cardiovasc Imaging 2017;10:e005628.
pubmed: 28687538
Duvall WL, Rai M, Ahlberg AW, O’Sullivan DM, Henzlova MJ. A multi-center assessment of the temporal trends in myocardial perfusion imaging. J Nucl Cardiol 2015;22:539-51.
doi: 10.1007/s12350-014-0051-x
Thompson RC, Allam AH. More risk factors, less ischemia, and the relevance of MPI testing. J Nucl Cardiol 2015;22:552-4.
doi: 10.1007/s12350-015-0072-0
Megna R, Zampella E, Assante R, Nappi C, Gaudieri V, Mannarino T, et al. Temporal trends of abnormal myocardial perfusion imaging in a cohort of Italian subjects: Relation with cardiovascular risk factors. J Nucl Cardiol 2019. https://doi.org/10.1007/s12350-019-01630-1 .
doi: 10.1007/s12350-019-01630-1 pubmed: 31823327
Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8.
doi: 10.1056/NEJM197906143002402
Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003;107:149-58.
doi: 10.1161/01.CIR.0000047041.66447.29
Genders TS, Steyerberg EW, Alkadhi H, Leschka S, Desbiolles L, Nieman K, et al. CAD Consortium. A clinical prediction rule for the diagnosis of coronary artery disease: Validation, updating, and extension. Eur Heart J 2011;32:1316-30.
doi: 10.1093/eurheartj/ehr014
Genders TS, Steyerberg EW, Hunink MG, Nieman K, Galema TW, Mollet NR, et al. Prediction model to estimate presence of coronary artery disease: Retrospective pooled analysis of existing cohorts. BMJ 2012;344:e3485.
doi: 10.1136/bmj.e3485
Reeh J, Therming CB, Heitmann M, Højberg S, Sørum C, Bech J, et al. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. Eur Heart J 2019;40:1426-35.
doi: 10.1093/eurheartj/ehy806
Megna R, Petretta M, Alfano B, Cantoni V, Green R, Daniele S, et al. A new relational database including clinical data and myocardial perfusion imaging findings in subjects with suspected or known coronary artery disease. Curr Med Imaging 2019;15:661-71.
doi: 10.2174/1573405614666180807110829
Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). ACC/AHA 2002 guideline update for exercise testing: Summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;2002(106):1883-92.
Verberne HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F, De Bondt P, et al. European Association of Nuclear Medicine (EANM). EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging 2015;2015(42):1929-40.
doi: 10.1007/s00259-015-3139-x
Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, Sciammarella MG, et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 2004;11:414-23.
doi: 10.1016/j.nuclcard.2004.03.033
Liu RZ, Zhao ZR, Ng CS. Statistical modelling for thoracic surgery using a nomogram based on logistic regression. J Thorac Dis 2016;8:E731-6.
doi: 10.21037/jtd.2016.07.91
Zhang J, Yang J, Wang HQ, Pan Z, Yan X, Hu C, Li Y, Lyu J. Development and validation of a nomogram for osteosarcoma-specific survival: A population-based study. Medicine 2019;98:e15988.
doi: 10.1097/MD.0000000000015988
Vickers AJ, Elkin EB. Decision curve analysis: A novel method for evaluating prediction Models. Med Decis Mak 2006;26:565-74.
doi: 10.1177/0272989X06295361
Berry C. Stable coronary syndromes. The case for consolidating the nomenclature of stable ischemic heart disease. Circulation 2017;136:437-9.
doi: 10.1161/CIRCULATIONAHA.117.028991
Perdoncin E, Duvernoy C. Treatment of coronary artery disease in women. Methodist Debakey Cardiovasc J 2017;13:201-8.
doi: 10.14797/mdcj-13-4-201
Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:2564-603.
doi: 10.1016/j.jacc.2012.07.012
Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2014;64:1929-49.
doi: 10.1016/j.jacc.2014.07.017
Bittencourt MS, Hulten E, Polonsky TS, Hoffman U, Nasir K, Abbara S, et al. European Society of Cardiology-Recommended Coronary Artery Disease Consortium pretest probability scores more accurately predict obstructive coronary disease and cardiovascular events than the diamond and forrester score: The partners registry. Circulation 2016;134:201-11.
doi: 10.1161/CIRCULATIONAHA.116.023396
Almeida J, Fonseca P, Dias T, Ladeiras-Lopes R, Bettencourt N, Ribeiro J, et al. Comparison of coronary artery disease Consortium 1 and 2 scores and Duke clinical score to predict obstructive coronary disease by invasive coronary angiography. Clin Cardiol 2016;39:223-8.
doi: 10.1002/clc.22515
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003.
doi: 10.1093/eurheartj/eht310.P4876
Baskaran L, Danad I, Gransar H, Hartaigh ÓB, Schulman-Marcus J, Lin FY, et al. A comparison of the updated diamond-forrester, CAD Consortium, and CONFIRM history-based risk scores for predicting obstructive coronary artery disease in patients with stable chest pain: The SCOT-HEART coronary CTA Cohort. JACC Cardiovasc Imaging 2019;12:1392-400.
doi: 10.1016/j.jcmg.2018.02.020
Johnson NP, Kirkeeide RL, Gould KL. Coronary anatomy to predict physiology: Fundamental limits. Circ Cardiovasc Imaging 2013;6:817-32.
doi: 10.1161/CIRCIMAGING.113.000373
Greene P, Prasad V, Cifu A. Should evidence come with an expiration date? J Gen Intern Med 2019;34:1356-7.
doi: 10.1007/s11606-019-05032-4
Beller GA. How should we interpret the decrease in annual volume of stress imaging tests for evaluation of suspected or known coronary artery disease with fewer high-risk test results? Circ Cardiovasc Imaging 2017;10:e006702.
doi: 10.1161/CIRCIMAGING.117.006702

Auteurs

Rosario Megna (R)

Institute of Biostructure and Bioimaging, National Council of Research, Naples, Italy.

Roberta Assante (R)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.

Emilia Zampella (E)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.

Valeria Gaudieri (V)

Institute of Biostructure and Bioimaging, National Council of Research, Naples, Italy.
Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.

Carmela Nappi (C)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.

Renato Cuocolo (R)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.

Teresa Mannarino (T)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.

Andrea Genova (A)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.

Roberta Green (R)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.

Valeria Cantoni (V)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.

Wanda Acampa (W)

Institute of Biostructure and Bioimaging, National Council of Research, Naples, Italy.
Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.

Mario Petretta (M)

Department of Translational Medical Sciences, University Federico II, Naples, Italy.

Alberto Cuocolo (A)

Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy. cuocolo@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH